 Home > Biochemistry News > Biotechnology News > 100% of patients get objective relief, and the latest clinical results of ready-to-use natural killer cell therapy are positive

100% of patients get objective relief, and the latest clinical results of ready-to-use natural killer cell therapy are positive

 Last Update: 2021-12-01
 Source: Internet
 Author: User

Tags

car therapy companies

natural argan oil

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 22, 2021, Affimed announced that its umbilical cord blood-derived natural killer cell therapy will be combined with the innate cell engager (ICE) AFM13 in advance to treat Hodgkins and patients who have received multi-line pre-treatment.

Natural killer (NK) cells are the innate immune cells that exist in the human body.

Affimed's strategy is to combine natural killer cells that have no targeting ability with the innate cell adaptor that gives them the ability to target

▲The mode of action of the combination of innate cell binders and NK cells (picture source: Affimed official website)

As of October 31, 2021, a total of 18 patients with CD30-positive relapsed/refractory Hodgkin’s lymphoma (n=16) and non-Hodgkin’s lymphoma (n=2) received different doses of this innovative treatment Treatment

The results of the trial showed that of the 18 patients, 16 patients achieved objective remissions, including 7 complete remissions (CR) and 9 partial remissions (PR)

In terms of safety, the treatment combination showed good tolerance

Reference materials:

[1]AffimedAnnounces100%ObjectiveResponseRateatHighestDoseinPhase1-2StudyofCordBlood-derivedNaturalKillerCellsPre-complexedwithInnateCellEngagerAFM13forCD30-positiveLymphomas.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Express 100% of patients get objective relief, and the latest clinical results of ready-to-use natural killer cell therapy are positive

12-05

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

100% of patients get objective relief, and the latest clinical results of ready-to-use natural killer cell therapy are positive

Related Articles

Express 100% of patients get objective relief, and the latest clinical results of ready-to-use natural killer cell therapy are positive